The analysis of economic availability of veterinary preparations in the segment of anti-mastitis medicines




medicines, cow mastitis, anti-mastitis veterinary preparations, price availability, veterinary drug market


Aim. To analyze the availability indexes of the preparations used for the treatment of mastitis in cattle, as well as to calculate the predicted prime cost of new anti-mastitis products compared to the prices of the reference drugs in order to identify the economic feasibility of their introduction into production.

Materials and methods. The theoretical basis of the study was the regulatory framework, scientific works of domestic and foreign scientists. The empirical research base was the price lists, state statistics data for 2012-2016. The calculations of price indexes, indexes of price liquidity and adequacy of solvency, the analysis of the dynamics of indicators were conducted using statistical methods. The prime cost of products was calculated by the conventional method.

Results. The analysis of legislation that regulates circulation and the quality control of veterinary preparations inUkraine and the EU countries indicates significant inconsistencies. It makes topical the problems of improving the normative base taking into account the international standards. The study of the availability of veterinary anti-mastitis preparations in 2012-2016 was conducted. As a result of the analysis of price indexes, indexes of price liquidity and availability of prices the conclusion can be made about the proper economic availability of this group of preparations. The prime cost calculation of anti-mastitis products proposed to introduction into production was performed. According to the results of calculations the predicted wholesale prices for the cream “Argocid-C”,100.0 g, the solution for intracisternal introduction “Argocid”, 100 ml, and the spray “Argocide-copper” are significantly cheaper than the prices for the reference drugs.

Conclusions. The veterinary preparations with the anti-mastitis action are available for agricultural enterprises of different forms of ownership and management. The veterinary preparations proposed for the treatment of mastitis in cows is economically feasible to produce.


Prokuratova, A. (2010). Veterinariia sel’skohoziaistvennyh zhyvotnyh, 11, 10–12.

Khanieiev, V. V., Yanchuk, T. V. (2011). Veterynarna medytsyna Ukrainy, 11 (189), 36–37.

Panchenko, A. A., Zagorulko, M. P., Voitenko, L. G., Chekrysheva, V. V. (2014). Estestvennye i medicinskie nauki, 10 (16). Retrieved from:

Bilchenko, H. (2011). Agroexpert, 8, 67–68.

Commission Directive 91/412/EEC of 23.07.1991 laying down the principles and guidelines of good manufacturing practice for veterinary medicinal products. (1991). Official Journal L 228, 70–73.

Directive 2001/82/EC of the European Parliament and of the Council of 6.11.2001 on the Community code relating to veterinary medicinal products. (2001). Official Journal L 311, 1–66.

Regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31.03.2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance).

Pro veterynarnu medytsynu. № 2498-XII. (1992). Retrieved from:

Dovhan, V. I. (2011). Universytetski naukovi zapysky, 3 (39), 387–392.

Bushuieva, I.V. (2013). Zaporozhskyi medytsynskyi zhurnal, 3 (78), 90–93.

Elektronnyi kataloh veterynarnykh preparativ. Retrieved from:

Prais lysty tsin na veterynarni preparaty. Retrieved from:

Prais lysty tsin na veterynarni preparaty. Retrieved from:

Nemchenko, A. S., Kosiachenko, K. L., Nemchenko, O. A. (2012). Tsinoutvorennia na likarski zasoby [Мedicine pricing]. Kharkiv: Apostrof, 304.

Nemchenko, A. S., Zharkova, S. O., Podhaina, M. V. (2012). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4 (24), 60–64.

Derzhavna sluzhba statystyky. Retrieved from:





Health organization